5th NASH Roundtable™ Virtual Forum

Is Digital Pathology a Game-Changer for Histology in NASH Drug Development?

Thursday June 16, 2022 | 11:30 AM PDT | 02:30 PM EDT

Forum for Collaborative Translational Research Opportunities

The 5th NASH Roundtable™ Virtual Forum was held on June 16, 2022, with presentations focused on the use of digital pathology for histology in NASH drug development.

Conference Summary (Available Soon)

A summary of the conference will be available soon. Join our mailing list here to be notified.

Forum co-chairs and moderators were

Arun J. Sanyal, MD

Z. Reno Vlahcevic Professor of Medicine at Virginia Commonwealth University School of Medicine

Rohit Loomba, MD

Professor of Medicine, Director of Hepatology, at University of California at San Diego and Founding Director of the UCSD NAFLD Research Center

Marcus Hompesch, MD

President & CEO, ProSciento, Inc. and Editor-in-Chief, Endocrinology, Diabetes & Metabolism

Keynote presenters included

Cindy Serdjebi, PharmD, PhD, Head of Research and Development, Biocellvia

Mathieu Petitjean, PhD, Chief Executive Officer, PHARMANEST

Janani Iyer, PhD, Scientific Program Manager, PathAI

Anil Parwani, MD, PhD, Vice Chair, Anatomical Pathology, and Director, Pathology Informatics and Digital Pathology, The Ohio State University, Wexner Medical Center

NASH Roundtable™ Members participating in the event included:

Elisabetta Bugianesi, MD, PhD, Professor of Gastroenterology, School Medicine at the University of Torino, Italy

Kenneth Cusi, MD, Professor & Chief, Division of Endocrinology, Diabetes & Metabolism, University of Florida

Scott Friedman, MD, Dean, Therapeutic Discovery and Chief, Division of Liver Diseases, at Icahn School of Medicine at Mount Sinai

Eric Lawitz, MD, Vice President, Scientific and Research Dev, Texas Liver Institute, and Clinical Prof of Medicine, University of Texas Health San Antonio

Rohit Loomba, MD, Professor & Director of Hepatology at University of California, San Diego, & Director, NAFLD Research Center

Vlad Ratziu, MD, PhD, Professor of Hepatology at Sorbonne Université and Pitié-Salpêtrière Hospital

Manuel Romero-Gómez, MD, Professor at University of Seville and Director of Digestive, Liver and Inflammatory Diseases Program at Institute of Biomedicine of Seville

Arun J. Sanyal, MD, the Reno Vlahcevic Professor of Medicine at Virginia Commonwealth University School of Medicine

Detlef Schuppan, MD, PhD, Professor, Hepatology & Gastroenterology at Mainz University & Beth Israel Medical Center, Harvard

Miriam Vos, MD, Professor, Pediatrics, Hepatology at Emory and Director, Pediatric Fatty Liver at Children’s Healthcare of Atlanta

Contact Us

Please email us directly at nashroundtable@prosciento.com for more information.

Hosted By

NASH roundtable

This event will be recorded and available for viewing approximately one week after the live event.

About NASH Roundtable

NASH Roundtable is a forum of leading hepatologists, endocrinologists and clinical development experts stewarding advances in science, clinical research and therapeutics for nonalcoholic fatty liver disease and steatohepatitis.

For questions or additional information please contact nashroundtable@prosciento.com or visit nashroundtable.com

The NASH Roundtable™ was established in 2018 as a platform to stimulate collaboration and build consensus towards validated biomarkers and endpoints and to support the development of effective and safe treatments. Today the Roundtable consists of distinguished physicians, researchers, and clinical development experts from three continents brought together by their common commitment to steward advances in science, clinical research, and therapeutics for fibrotic diseases.